GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (FRA:5V7) » Definitions » EBITDA Margin %

VentriPoint Diagnostics (FRA:5V7) EBITDA Margin % : -1,823.26% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is VentriPoint Diagnostics EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. VentriPoint Diagnostics's EBITDA for the three months ended in Sep. 2024 was €-0.78 Mil. VentriPoint Diagnostics's Revenue for the three months ended in Sep. 2024 was €0.04 Mil. Therefore, VentriPoint Diagnostics's EBITDA margin for the quarter that ended in Sep. 2024 was -1,823.26%.


VentriPoint Diagnostics EBITDA Margin % Historical Data

The historical data trend for VentriPoint Diagnostics's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VentriPoint Diagnostics EBITDA Margin % Chart

VentriPoint Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,792.73 -4,369.57 - -7,087.23 -9,833.33

VentriPoint Diagnostics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2,860.71 - -4,423.81 -1,823.26

Competitive Comparison of VentriPoint Diagnostics's EBITDA Margin %

For the Medical Devices subindustry, VentriPoint Diagnostics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VentriPoint Diagnostics's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's EBITDA Margin % falls into.



VentriPoint Diagnostics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

VentriPoint Diagnostics's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-3.245/0.033
=-9,833.33 %

VentriPoint Diagnostics's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-0.784/0.043
=-1,823.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VentriPoint Diagnostics  (FRA:5V7) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


VentriPoint Diagnostics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


VentriPoint Diagnostics Business Description

Traded in Other Exchanges
Address
18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.

VentriPoint Diagnostics Headlines

No Headlines